| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776274 | Urology | 2017 | 18 Pages |
Abstract
For all patients, the 10-year OM was about 3 times higher than PCSM, the greatest and lowest discrepancies emerging among patients with low- and high-risk tumors, respectively. The results support increased use of local treatment in high-risk patients. GGGs should be implemented in clinical practice. The role of ECOG performance status as prognostic factor has to be validated in future studies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kirsti Aas, Karol Axcrona, Rune KvÃ¥le, Bjørn Møller, Tor Ã
ge Myklebust, Ulrika Axcrona, Viktor Berge, Sophie Dorothea Fosså,